You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Moodys
Medtronic
Harvard Business School

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

FELODIPINE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for felodipine and what is the scope of patent protection?

Felodipine is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Glenmark Generics, Heritage Pharms Inc, Jubilant Generics, Mylan, Orchid Hlthcare, Sun Pharm Inds Ltd, Sun Pharm Industries, Torrent Pharms Ltd, Vintage Pharms Llc, Wockhardt Ltd, Yiling, Yung Shin Pharm, and Astrazeneca, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for felodipine. Fifteen suppliers are listed for this compound.

Drug Prices for FELODIPINE

See drug prices for FELODIPINE

Drug Sales Revenue Trends for FELODIPINE

See drug sales revenues for FELODIPINE

Recent Clinical Trials for FELODIPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rigshospitalet, DenmarkPhase 4
Lawson Health Research InstitutePhase 1
Lee's Pharmaceutical LimitedPhase 4

See all FELODIPINE clinical trials

Pharmacology for FELODIPINE
Medical Subject Heading (MeSH) Categories for FELODIPINE
Paragraph IV (Patent) Challenges for FELODIPINE
Tradename Dosage Ingredient NDA Submissiondate
PLENDIL TABLET, EXTENDED RELEASE;ORAL felodipine 019834

US Patents and Regulatory Information for FELODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 091484-001 Aug 15, 2012 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Aurobindo Pharma Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 203417-003 Jan 17, 2013 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Yiling FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 210847-003 Oct 26, 2018 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Wockhardt Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 091484-002 Aug 15, 2012 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Heritage Pharms Inc FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 201964-001 Nov 8, 2013 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FELODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-001 Jul 25, 1991   Get Started for $10   Get Started for $10
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-004 Sep 22, 1994   Get Started for $10   Get Started for $10
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-002 Jul 25, 1991   Get Started for $10   Get Started for $10
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-001 Jul 25, 1991   Get Started for $10   Get Started for $10
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-002 Jul 25, 1991   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Moodys
Baxter
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.